SeaCrest Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-300
| Closed | -$44K | – | 656 |
|
|
2022
Q2 | $44K | Buy |
+300
| New | +$44K | 0.01% | 1170 |
|
|
2019
Q2 | – | Sell |
-400
| Closed | -$37K | – | 567 |
|
|
2019
Q1 | $37K | Hold |
400
| – | – | 0.01% | 1046 |
|
|
2018
Q4 | $29K | Hold |
400
| – | – | 0.01% | 1087 |
|
|
2018
Q3 | $35K | Buy |
400
+100
| +33% | +$8.75K | 0.01% | 1141 |
|
|
2018
Q2 | $30K | Sell |
300
-100
| -25% | -$10K | 0.01% | 1186 |
|
|
2018
Q1 | $48K | Hold |
400
| – | – | 0.01% | 964 |
|
|
2017
Q4 | $51K | Buy |
+400
| New | +$51K | 0.01% | 948 |
|